NCT00525603 - CFAR Study in Patients With Chronic Lymphocytic Leukemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions

LeukemiaChronic Lymphocytic Leukemia

Interventions

DRUG

Cyclophosphamide

200 mg/m\^2/day 3-5 IV 5-30 minutes

DRUG

Fludarabine

20 mg/m\^2/day 3-5 IV 5-30 minutes

DRUG

Alemtuzumab

30 mg Days 1, 3, 5 IV 2-4 hours

DRUG

Rituximab

375 mg/m\^2/day 2 IV 4-6 hours

Trial Locations (1)

The University of Texas M.D. Anderson Cancer Center, Houston